| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $607K | +140.5% |
| Cost of Revenue | $147K | — |
| R&D Expense | $1.2M | +27.7% |
| SG&A Expense | $285K | +7726.3% |
| Operating Income | -$3.9M | -65.7% |
| Interest Expense | $20K | — |
| Income Tax | $0 | — |
| Net Income | -$3.9M | -66.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $31K | -95.0% |
| Current Assets | $31K | -95.0% |
| Total Assets | $1.2M | -0.4% |
| Current Liabilities | $730K | -64.2% |
| Total Liabilities | $796K | -61.0% |
| Stockholders' Equity | $426K | +152.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.6M | -150.8% |
| Capital Expenditures | $7K | +148.4% |
| Investing Cash Flow | -$398K | +9.8% |
| Financing Cash Flow | $2.4M | +83.4% |
| Free Cash Flow | -$2.6M | -150.8% |